It should be emphasized that the range of risk reduction of the toxic maculopathy-associated ABCA4 variants is well comparable to odds ratios of non-risk alleles at the CFH or ARMS2/HTRA1 loci, two genomic regions which are considered to be strongly associated with large effect sizes with the development of AMD [25]. This evidence concerns the gene ARMS2 and age-related macular degeneration.